TIMP2 and acute kidney injury: Among the most recent ones, urinary tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor binding protein 7 (IGFBP7) product have been proven to be a good predictor of AKI [5] and received FDA approval for AKI risk assessment in critically ill patients.